Author: Sky York Journal

SKY YORK JOURNAL News – Sanofi is significantly expanding its respiratory vaccine pipeline through a strategic acquisition. Sanofi is set to acquire Vicebio for $1.15 billion, according to a press release, a move reported by the SKY YORK JOURNAL highlighting Sanofi’s commitment to vaccine innovation. This acquisition grants the pharmaceutical giant access to Vicebio’s promising respiratory vaccine candidates and its innovative platform technology. Sanofi aims to leverage this technology to develop vaccines capable of targeting multiple pathogens with a single dose, potentially alleviating the burden of multiple shots for patients. **Deal Terms and Vicebio’s Pipeline** In addition to the substantial…

SKY YORK JOURNAL News – Private equity firm TSG Consumer Partners has expanded its portfolio with the acquisition of indie fragrance label Phlur, further solidifying its presence in the beauty sector. The financial terms of the deal remain undisclosed. **Phlur’s Recent Growth** Phlur experienced a significant relaunch in February 2022, spearheaded by brand accelerator The Center and influencer Chriselle Lim. According to reports, this revitalization has positioned Phlur as the second-fastest-growing brand at Sephora locations across the United States and Canada. The *SKY YORK JOURNAL* has been following the company’s development with interest. **TSG’s Beauty Investments** This acquisition follows TSG…

SKY YORK JOURNAL News – U.S. Immigration and Customs Enforcement (ICE) is reportedly expanding its arrest operations, according to a top official. Speaking on Fox News last week, ICE Deputy Director Madison Sheahan stated that the agency was broadening its focus for arrests. “I think we all know that criminals tend to hang out with criminals,” Sheahan said. “And so when we start to build a case, we’re going to be going after everyone that’s around them. Because these criminals tend to hang out with like-minded people who also happen to be criminals.” This pledge to broaden arrests comes amidst…

Sky York Journal President Donald Trump appears to be quietly reviving a plan from his first term that would kick families of mixed immigration status out of public housing and prohibit them from receiving most forms of rental assistance, escalating his administration’s attacks on access to public services for immigrant communities. Last Wednesday, the Trump administration posted a proposed rule for the Department of Housing and Urban Development to the Office of Information and Regulatory Affairs, or OIRA. While details were scant on the website, the language mirrors an abandoned 2019 proposal that would have increased documentation requirements for federal…

Sky York Journal What was Donald Trump thinking about the Jeffrey Epstein files?Maybe this:It’s the middle of 2024, and the Epstein files are important to my presidential campaign. My base thinks the files will prove that Democratic pedophiles run the country. I’m supposed to release the files, expose the pedophiles, and cleanse the country of the Democratic elite cabal.Does anyone really believe that crap? Thank God for QAnon.Anyway, I realize there’s a bunch of stuff in the Epstein files that makes me look pretty bad. The heck with it! I’ll commit to release the files anyway. Maybe folks will have…

Sky York Journal Christine Hunsicker, former CEO of fashion rental company CaaStle, surrendered to authorities on Friday after the U.S. Attorney’s office in Manhattan indicted her on charges of wire fraud, securities fraud, money laundering, making false statements to a financial institution and aggravated identity theft. All charges carry a maximum sentence of 20 years in prison, except for the charge of making false statements to a financial institution, which could land Hunsicker up to 30 years in prison. Christine Hunsicker Indicted in $300M Fashion Rental Fraud Case [WWD]

Sky York Journal On Friday, a federal judge in New York dismissed Donald Trump’s copyright suit against Bob Woodward and Simon and Schuster. So much for the president’s plan to extort $50 million from the publisher for conspiracy to collate and cobble! But when God closes a door, she opens a window. And so that very same day, Trump filed a $10 billion dollar defamation suit against the Wall Street Journal and its owner Rupert Murdoch.Trump denies that in 2003 he contributed a crude drawing to a book of “bawdy letters” compiled for pedophile Jeffrey Epstein’s 50th birthday, as reported by…

Sky York Journal A&O Shearman’s securities litigation practice is a little lighter. As of today, New York-based partner Agnès Dunogué has moved firms, opting to continue her career at Freshfields. Freshfields’ co-head of securities and shareholder litigation Mary Eaton said of the move, “I’ve had the privilege of litigating in the same securities space as Agnès for a number of years. She will be a key driver in the next phase of the team’s growth in the US.” Bloomberg Law, which broke the story of the lateral move, couches it in terms of the battle between U.K.-based firms (both Freshfields and…

Sky York Journal There’s a fundamental architectural flaw in how the internet works that most people have never heard of, but it explains nearly every frustration you have with modern technology. Why your photos are trapped in Apple’s ecosystem. Why you can’t easily move data between apps. Why every promising new service starts from scratch, knowing nothing about you. And most importantly, why AI—for all its revolutionary potential—risks making Big Tech even bigger instead of putting powerful tools in your hands. Former Google and Stripe executive Alex Komoroske (who recently wrote for us about why the future of AI need…

Sky York Journal For the third time this year, a patient treated with a Sarepta Therapeutics gene therapy has died, a revelation that comes as the company tries to earn back patient and investor trust amid a series of safety setbacks. The first two fatalities were teenage boys treated with the commercialized Duchenne muscular dystrophy gene therapy Elevidys. The latest fatality was a 51-year-old man who received SRP-9004, an experimental gene therapy for limb-girdle muscular dystrophy 2D/R3. All three patients died after developing acute liver failure. BioCentury first reported the latest fatality late Thursday. Sarepta confirmed the development, then held a conference…